It’s a serious heart defect that can cause blood to flow into the wrong part of the heart chamber, and up until recently, it ...

This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

Kenneth Liao, MD, PhD, completed his 900th robotic heart surgery in December.  Robotic procedures that Dr. Liao and his team ...

Routine echocardiography in cancer centers can spot severe valve disease earlier and trigger timely treatment decisions.

"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.

IRVINE, California - Edwards Lifesciences (NYSE:EW) has received U.S. Food and Drug Administration approval for its SAPIEN M3 mitral valve replacement system, marking the first transcatheter therapy ...

The success of TAVR has also sparked research into transcatheter solutions for other valve diseases, including mitral and ...

Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced ...

Irvine, California Friday, December 26, 2025, 11:00 Hrs [IST] ...